{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:31:44Z","timestamp":1787981504412,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s10557-015-6584-7","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T20:20:06Z","timestamp":1428610806000},"page":"187-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly"],"prefix":"10.1007","volume":"29","author":[{"given":"Liang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Jiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai Leng","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Chee Seong","family":"Seet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quek Wei","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiong Cheng","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Peng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,11]]},"reference":[{"key":"6584_CR1","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1161\/hc4601.099487","volume":"104","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746\u201353.","journal-title":"Circulation"},{"key":"6584_CR2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670\u201381.","journal-title":"Lancet"},{"key":"6584_CR3","doi-asserted-by":"crossref","unstructured":"Taylor F, Ward K, Moore TH, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2011; CD004816.","DOI":"10.1002\/14651858.CD004816.pub4"},{"key":"6584_CR4","doi-asserted-by":"crossref","first-page":"b2376","DOI":"10.1136\/bmj.b2376","volume":"338","author":"JJ Brugts","year":"2009","unstructured":"Brugts JJ, Yetgin T, Hoeks SE, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ (Clin Res ed). 2009;338:b2376.","journal-title":"BMJ (Clin Res ed)"},{"key":"6584_CR5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)62027-3","volume":"380","author":"B Mihaylova","year":"2012","unstructured":"Mihaylova B, Emberson J, Blackwell L, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581\u201390.","journal-title":"Lancet"},{"key":"6584_CR6","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology\/american heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63:2889\u2013934.","journal-title":"J Am Coll Cardiol"},{"key":"6584_CR7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jama.2013.284657","volume":"311","author":"JA Ioannidis","year":"2014","unstructured":"Ioannidis JA. More than a billion people taking statins? Potential implications of the new cardiovascular guidelines. JAMA: J Am Med Assoc. 2014;311:463\u20134.","journal-title":"JAMA: J Am Med Assoc"},{"key":"6584_CR8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/CIRCULATIONAHA.110.986349","volume":"124","author":"LD Lazar","year":"2011","unstructured":"Lazar LD, Pletcher MJ, Coxson PG, et al. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation. 2011;124:146\u201353.","journal-title":"Circulation"},{"key":"6584_CR9","doi-asserted-by":"crossref","first-page":"d1672","DOI":"10.1136\/bmj.d1672","volume":"342","author":"JP Greving","year":"2011","unstructured":"Greving JP, Visseren FL, de Wit GA, et al. Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis. BMJ (Clin Res ed). 2011;342:d1672.","journal-title":"BMJ (Clin Res ed)"},{"key":"6584_CR10","first-page":"178","volume":"11","author":"S Ward","year":"2007","unstructured":"Ward S, Lloyd Jones M, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess. 2007;11:178.","journal-title":"Health Technol Assess"},{"key":"6584_CR11","unstructured":"The State of Aging and Health in America 2013. In: Centers for Disease Control and Prevention UDoHaHS, ed. Atlanta, GA, 2013."},{"key":"6584_CR12","unstructured":"Health at a Glance 2013. OECD Indicators. OECD Publishing, 2013."},{"key":"6584_CR13","unstructured":"Department of Statistics, Singapore. Complete life tables 2008\u20132013 for Singapore Resident Population. Available at: http:\/\/www.singstat.gov.sg\/publications\/publications_and_papers\/births_and_deaths\/lifetable08-13.pdf . Last accessed 1 December 2014."},{"key":"6584_CR14","unstructured":"Office for National Statistics, United Kingdom. National life tables 2011\u20132013. Available at: http:\/\/www.ons.gov.uk\/ons\/taxonomy\/index.html?nscl=Life+Tables#tab-data-tables . Last accessed 1 December 2014."},{"key":"6584_CR15","series-title":"National vital statistics reports","volume-title":"United States life tables, 2010","author":"E Arias","year":"2014","unstructured":"Arias E. United States life tables, 2010, National vital statistics reports, vol. 7. 63rd ed. Hyattsville: National Center for Health Statistics; 2014.","edition":"63"},{"issue":"9","key":"6584_CR16","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/hs0901.094253","volume":"32","author":"H Br\u00f8nnum-Hansen","year":"2001","unstructured":"Br\u00f8nnum-Hansen H, Davidsen M, Thorvaldsen P, et al. Long-term survival and causes of death after stroke. Stroke. 2001;32(9):2131\u20136. September 1, 2001.","journal-title":"Stroke"},{"issue":"4","key":"6584_CR17","first-page":"532","volume":"5","author":"K Smolina","year":"2012","unstructured":"Smolina K, Wright FL, Rayner M, et al. Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010. Circ: Cardiovasc Qual Outcomes. 2012;5(4):532\u201340. July 1, 2012.","journal-title":"Circ: Cardiovasc Qual Outcomes"},{"issue":"6","key":"6584_CR18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1525-1497.2004.30516.x","volume":"19","author":"JJ Ellis","year":"2004","unstructured":"Ellis JJ, Erickson SR, Stevenson JG, et al. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med. 2004;19(6):638\u201345.","journal-title":"J Gen Intern Med"},{"key":"6584_CR19","first-page":"47","volume":"8","author":"S Bhardwaj","year":"2013","unstructured":"Bhardwaj S, Selvarajah S, Schneider EB. Muscular effects of statins in the elderly female: a review. Clin Interv Aging. 2013;8:47\u201359.","journal-title":"Clin Interv Aging"},{"key":"6584_CR20","doi-asserted-by":"crossref","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","volume":"97","author":"M Law","year":"2006","unstructured":"Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol. 2006;97:52C\u201360C.","journal-title":"Am J Cardiol"},{"key":"6584_CR21","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.0b013e3182a9f45f","volume":"81","author":"R Luengo-Fernandez","year":"2013","unstructured":"Luengo-Fernandez R, Gray AM, Bull L, et al. Quality of life after TIA and stroke: ten-year results of the Oxford vascular study. Neurology. 2013;81:1588\u201395.","journal-title":"Neurology"},{"key":"6584_CR22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCULATIONAHA.107.752006","volume":"118","author":"J Xie","year":"2008","unstructured":"Xie J, Wu EQ, Zheng Z-J, et al. Patient-reported health status in coronary heart disease in the United States: age, sex, racial, and ethnic differences. Circulation. 2008;118:491\u20137.","journal-title":"Circulation"},{"key":"6584_CR23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-144-5-200603070-00007","volume":"144","author":"M Pignone","year":"2006","unstructured":"Pignone M, Earnshaw S, Tice JA, et al. Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Ann Intern Med. 2006;144:326\u201336.","journal-title":"Ann Intern Med"},{"key":"6584_CR24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.7326\/0003-4819-150-4-200902170-00005","volume":"150","author":"MJ Pletcher","year":"2009","unstructured":"Pletcher MJ, Lazar L, Bibbins-Domingo K, et al. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med. 2009;150:243\u201354.","journal-title":"Ann Intern Med"},{"key":"6584_CR25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jemermed.2005.08.020","volume":"31","author":"DH Schreiber","year":"2006","unstructured":"Schreiber DH, Anderson TR. Statin-induced rhabdomyolysis. J Emerg Med. 2006;31:177\u201380.","journal-title":"J Emerg Med"},{"key":"6584_CR26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/ajhp\/60.6.578","volume":"60","author":"MZ Skrabal","year":"2003","unstructured":"Skrabal MZ, Stading JA, Cannella CA, et al. Two cases of rhabdomyolysis associated with high-dose simvastatin. Am J Health Syst Pharm: AJHP: Off J Am Soc Health Syst Pharm. 2003;60:578\u201381.","journal-title":"Am J Health Syst Pharm: AJHP: Off J Am Soc Health Syst Pharm"},{"key":"6584_CR27","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.apmr.2009.01.027","volume":"90","author":"WS Tan","year":"2009","unstructured":"Tan WS, Heng BH, Chua KS, et al. Factors predicting inpatient rehabilitation length of stay of acute stroke patients in Singapore. Arch Phys Med Rehabil. 2009;90:1202\u20137.","journal-title":"Arch Phys Med Rehabil"},{"key":"6584_CR28","unstructured":"Department of Statistics, Singapore. Latest data on GDP per capita. Available at: http:\/\/www.singstat.gov.sg\/statistics\/latest_data.html#1 . Last accessed 1 September 2014."},{"key":"6584_CR29","unstructured":"Sachs JD. Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commision on Macroeconomics and Health. Geneva, Switzerland: World Health Organisation, 2011. Available at: http:\/\/whqlibdoc.who.int\/publications\/2001\/924154550x.pdf . Accessed on 1 September 2014."},{"key":"6584_CR30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2011.09.067","volume":"59","author":"WJ Kostis","year":"2012","unstructured":"Kostis WJ, Cheng JQ, Dobrzynski JM, et al. Meta-analysis of statin effects in women versus men. J Am Coll Cardiol. 2012;59:572\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"6584_CR31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.0000000000000208","volume":"82","author":"CD Bushnell","year":"2014","unstructured":"Bushnell CD, Reeves MJ, Zhao X, et al. Sex differences in quality of life after ischemic stroke. Neurology. 2014;82:922\u201331.","journal-title":"Neurology"},{"key":"6584_CR32","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1161\/CIRCULATIONAHA.107.182616","volume":"115","author":"KP Alexander","year":"2007","unstructured":"Alexander KP, Newby LK, Armstrong PW, et al. Acute coronary care in the elderly, part II: ST-segment\u2013elevation myocardial infarction: a scientific statement for healthcare professionals from the American heart association council on clinical cardiology: in collaboration with the society of geriatric cardiology. Circulation. 2007;115:2570\u201389.","journal-title":"Circulation"},{"key":"6584_CR33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0735-1097(01)01432-2","volume":"38","author":"RH Mehta","year":"2001","unstructured":"Mehta RH, Rathore SS, Radford MJ, et al. Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol. 2001;38:736\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"6584_CR34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/HJH.0b013e328342c8f7","volume":"29","author":"DJ Collier","year":"2011","unstructured":"Collier DJ, Poulter NR, Dahlof B, et al. Impact of atorvastatin among older and younger patients in the Anglo-Scandinavian cardiac outcomes trial lipid-lowering arm. J Hypertens. 2011;29:592\u20139.","journal-title":"J Hypertens"},{"key":"6584_CR35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1076-7460.2003.02000.x","volume":"12","author":"E Bruckert","year":"2003","unstructured":"Bruckert E, Lievre M, Giral P, et al. Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients. Am J Geriatr Cardiol. 2003;12:225\u201331.","journal-title":"Am J Geriatr Cardiol"},{"key":"6584_CR36","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.2337\/dc06-0872","volume":"29","author":"HA Neil","year":"2006","unstructured":"Neil HA, DeMicco DA, Luo D, et al. Analysis of efficacy and safety in patients aged 65\u201375\u00a0years at randomization: collaborative atorvastatin diabetes study (CARDS). Diabetes Care. 2006;29:2378\u201384.","journal-title":"Diabetes Care"},{"key":"6584_CR37","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)12475-0","volume":"361","author":"R Collins","year":"2003","unstructured":"Collins R, Armitage J, Parish S, et al. MRC\/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005\u201316.","journal-title":"Lancet"},{"key":"6584_CR38","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-152-8-201004200-00005","volume":"152","author":"RJ Glynn","year":"2010","unstructured":"Glynn RJ, Koenig W, Nordestgaard BG, et al. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med. 2010;152:488\u201396. W174.","journal-title":"Ann Intern Med"},{"key":"6584_CR39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/11595620-000000000-00000","volume":"28","author":"N Nakaya","year":"2011","unstructured":"Nakaya N, Mizuno K, Ohashi Y, et al. Low-dose pravastatin and age-related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study). Drugs Aging. 2011;28:681\u201392.","journal-title":"Drugs Aging"},{"key":"6584_CR40","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","volume":"360","author":"J Shepherd","year":"2002","unstructured":"Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623\u201330.","journal-title":"Lancet"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-015-6584-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-015-6584-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-015-6584-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T02:01:36Z","timestamp":1566525696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-015-6584-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["6584"],"URL":"https:\/\/doi.org\/10.1007\/s10557-015-6584-7","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}